Our pivot point stands at 23.9. Our preference The upside prevails as long as 23.9 is support. Alternative scenario Below 23.9, expect 22.5 and 21.6. Comment The RSI is above 50. The MACD is above its signal line and positive. The configuration is positive. Moreover, the stock is trading above both its 20 and 50 day moving average (respectively at 24.6825...
Clover Health - Intraday - We look to Buy at 2.01 (stop at 1.89) Support is located at 2.00 and should stem dips to this area. Trading close to the psychological 2.00 level. 2.00 continues to hold back the bears. We are trading at oversold extremes. We look for a temporary move lower. We look to buy dips. Our profit targets will be 2.37 and 2.47...
Holding well above daily EMAs ++ Constructive buying volume in last few months ++ Building below 200 DMA, could find some resistance, but with ER on 08/08 things could get interesting above. -- Disclosure: I am long since 2.56
I like how well the range has been last few weeks. Despite huge sell-off in the growth names, this one has found bids. Personally, I am not a big fan of microcaps, but this one has my attention because of the business. Insurance names have reported big ERs and look strong. This is a new company trying to carve a niche in that space. Chart is setting up...
Clover Health Short Term We look to Buy at 2.10 (stop at 1.93) A higher correction is expected. 2.00 has been pivotal. Although the anticipated move higher is corrective, it does offer ample risk/reward today. We therefore, prefer to fade into the dip with a tight stop in anticipation of a move back higher. Our profit targets will be 2.65 and 2.95...
Same as last post on QLGN... These ChARTs are macro bullish!
Laying it down... TNXP DJI BTC ITRM THMO QLGN CLOV ARDX NAKD @dRends35 this one is for you my friend across the pond!
Big boy Bullish Divergence. Falling wedge. The herd will come!
I have researched where to put my money. I've switched a couple of times as the markets have changed. One thing I have noticed is that the BioPharmaceutical, Pharmaceutical, BioTech, and a SPAC thrown into the mix for good measure were all in the same exact pattern. They all have been heavily shorted since Feb 2021... They are all down 80-90% over the year....
Where's the Alpha? Where am I at in these markets? BioFink lives!
These ChARTs are amazing! All in a similar setup. This first target is epic! $27 in play from this falling wedge. Fink is back in 6... TNXP, ITRM, THMO, ARDX, CLOV, & QLGN... BIOTECH and a Healthcare SPAC! DELTA - OMNICRON... I saw the anagram as soon as they posted that name after DELTA. MEDIA-CON(N)TROL... SAME as COVID... It's all in front of...
Went on an 80% run... This setup looks primed for a climb. Bullish Divergence. Sitting on opening price trendline. I'll take a stab!
Zigzag again with more drops on the cards for this one. Somewhere at the End of Wave C on this one. Confirms inplace means risk hedging, yet lower margins on profit per trade. This is likely to be the case here as well. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are...
Into the final minutes, $DWAC was trading at $39 a share at about 3:58pm. It then flushed to $36.69 by 3:59 only to reverse and close at $42.29 by 4pm. It hit a high of $59.39 before closing at $55.40 after hours. This is off of news that they have reached a fundraising target. With Jack gone and the recent distribution in names like $TWTR and $FB, is this a...
Clover Health Investments Corp (NASDAQ:CLOV) The company has done so many positive things in 2021. Currently at $7.17 this stock could be one of those huge high short interest stock runners. Patience is difficult in this market but can also pay off handsomely. I do think this stock will bounce back over $9.10 EMA200
NASDAQ:CLOV Above 8$ is bullish for Long position and below 7.40 is bearish for Short position Personally a rally to 7.70$ and maybe 8$ and then rejection. *This is my idea and could be wrong 100%
In the last couple of months, $CLOV has seen a lot of volatility in the daily chart, current prices are close to support, and we could see a bounce to the 100 or 200 EMA if volume grows.